Helus Pharma Inc. Common Stock
HELP
107 hedge funds and large institutions have $130M invested in Helus Pharma Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 15 closing their positions.
455% more capital invested
Capital invested by funds: $23.5M → $130M (+$107M)
140% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 15
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
62.65% more ownership
Funds ownership: 14.1% → 76.76% (+63%)
24% more funds holding
Funds holding: 86 → 107 (+21)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$22.1M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$15.2M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$13.3M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$9.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.23M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$3.66M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.14M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$106K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$90.9K |
HELP Hedge Fund Activity: Q1 2024 in Review
107 of the 6,962 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q1 2024, worth a combined $130M — up 455% from $23.5M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new HELP positions and 15 closed out — a net gain of 21 holders — while 19 added to existing stakes and 8 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $22.1M. The largest seller was Point72 Asset Management, cutting an estimated $6.23M.
- 107 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q1 2024, up from 86 in Q4 2023.
- Funds reported $130M of Helus Pharma Inc. Common Stock stock for Q1 2024, up 455% quarter-over-quarter.
- 36 funds opened new Helus Pharma Inc. Common Stock positions in Q1 2024 and 15 closed out, a net change of +21 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q1 2024 was Deep Track Capital, an estimated $22.1M added.
- The largest Helus Pharma Inc. Common Stock seller in Q1 2024 was Point72 Asset Management, an estimated $6.23M sold.
Based on aggregated 13F filings for Q1 2024.